onkopedia.com › de › morbus-castleman

2.1 Definition und Basisinformation. Unter der Bezeichnung Morbus Castleman (Synonyma: Castleman-Erkrankung, angiofollikuläre Lymphknoten-Hyperplasie, Riesenlymphknotenhyperplasie) wird eine seltene, heterogene Gruppe von Erkrankungen mit charakteristischen histopathologischen Veränderungen der Lymphknoten erfasst.

de.wikipedia.org › wiki › Morbus_Castleman

Morbus Castleman ( Castleman-Krankheit) ist eine heterogene Gruppe von Tumoren der Lymphknoten, die auch als angiofollikuläre Lymphknoten-Hyperplasie oder Riesenlymphknoten-Hyperplasie bezeichnet werden. Einteilung. Auch wenn alle Tumoren ähnliche histologische Eigenschaften teilen, gibt…

nature.com › articles › s41572-021-00317-7

Castleman disease (CD), a heterogeneous group of disorders that share morphological features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical presentation and ...

1. NOV. 2019

jnccn.org › view › article-p1417

Castleman disease is a heterogeneous nonmalignant lymphoproliferative disorder. Major distinctions include unicentric versus multicentric presentation; hyaline vascular, plasmacytic, or mixed pathology; and HHV8-associated (typically HIV-positive) versus idiopathic disease. At the…

onlinelibrary.wiley.com › doi › bjh

Castleman disease (CD) describes a rare group of lymphoproliferative disorders with characteristic histopathological appearances. 1 Unicentric CD (UCD) presents with isolated lymphadenopathy, usually accompanied by mild or localised symptoms. In…

pubmed.ncbi.nlm.nih.gov › 28486739

Castleman's disease is a very rare and potentially severe lymphoproliferative disorder. First sign may be cervical lymphadenitis, requiring sufficient support in diagnosis and therapy by an ENT specialist. Based on…

mdedge.com › podcasts › blood-cancer › castleman-disease-dr-david-fajgenbaum

Dr. Fajgenbaum can be reached at davidfa@pennmedicine.upenn.edu. More information about Castleman disease can be found at www.cdcn.org. Dr. Fajgenbaum’ s memoir is Chasing My Cure: A Doctor’ s Race to Turn Hope…

sciencedirect.com › science › S2210261222005284

Castleman's disease (CD) is a rare, often poorly understood lymphoproliferative disorder that shares common lymph node histological features. The disease was first described by Dr. Benjamin Castleman in a single…

pubmed.ncbi.nlm.nih.gov › 29157618

The term Castleman disease encompasses several distinct lymphoproliferative disorders with different underlying disease pathogenesis, and clinical outcomes. It includes unicentric and multicentric diseases with limited versus significant systemic symptoms, respectively.…

castleman.eu › en › castleman-disease-classification

Damaged lymph nodes such as those observed in Castleman disease may be symptomatic of other diseases. These are not true Castleman diseases. These are not true Castleman diseases. Castleman disease…

ojrd.biomedcentral.com › articles › 10.1186 › s13023-020-1345-5

Background Castleman disease (CD) is a rare non-malignant lymphoproliferation of undetermined origin. Two major disease phenotypes can be distinguished: unicentric CD (UCD) and multicentric CD (MCD). Diagnosis confirmation is based…

neeva.com › massets › ask-neeva › castleman-s-disease-specialist

Castleman Disease is a rare disorder that affects the lymph system and causes symptoms similar to the flu. It is classified as unicentric or multicentric based on how many regions…

22. AUG. 2019

cdcn.org › castleman-disease › faq

Castleman disease is a group of rare disorders characterized by lymph node enlargement, specific microscopic changes to the lymph nodes, and a broad range of symptoms and laboratory findings. The…

pubmed.ncbi.nlm.nih.gov › 34824298

Castleman disease (CD), a heterogeneous group of disorders that share morphological features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical presentation and disease course. Unicentric…

thelancet.com › journals › fulltext

Our systematic review provides comprehensive information about clinical features, treatment, and outcomes of idiopathic multicentric Castleman's disease , which accounts for at least 33% of all cases of multicentric Castleman's disease.…